Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Avicanna (AVCN) has entered into a Master Supply Agreement with Chilean pharmaceutical company Knop Laboratorios S.A.
  • Santa Marta Golden Hemp will supply cannabinoid-based pharmaceutical ingredients to Knop for the manufacture of proprietary cannabinoid-based pharmaceutical products
  • Knop Laboratorios S.A. is a Chilean pharmaceutical company and pioneer in herbal medicine with a presence in several Latin American countries
  • Avicanna is a commercial-stage biopharmaceutical company focused on developing cannabinoid-based products
  • Avicanna Inc. (AVCN) is down 1.79 per cent on the day, trading at C$0.55 per share at 1:50 pm EST

Through its subsidiary Santa Marta Golden Hemp, Avicanna (AVCN) has entered into a supply agreement with Chilean pharmaceutical company Knop Laboratorios S.A.

Santa Marta Golden Hemp will supply Knop with a range of cannabinoid-based active pharmaceutical ingredients for the manufacture of proprietary cannabinoid-based pharmaceutical products in Latin America.

Since 2018, Avicanna and Knop have developed a collaborative enterprise that has led to commercial imports of Avicanna´s API, including CBD and THC, which have been used in the development, production and commercialization of several cannabinoid-based products.

Through this master supply agreement, the two companies are preparing for the industrialization of Knop’s cannabinoid-based pharmaceuticals manufactured using Avicanna’s organic, sustainable inputs.

Knop Laboratorios S.A. is a Chilean pharmaceutical company and pioneer in herbal medicine with a presence in several Latin American countries including Chile, Ecuador, Colombia, Bolivia, Paraguay, and Peru. With a GMP-certified plant located in Quilpué, Chile, Knop Laboratorios manufactures high-quality pharmaceutical products including Cannabiol®.

Avicanna is a commercial-stage biopharmaceutical company focused on cannabinoid-based products.

Avicanna Inc. (AVCN) is down 1.79 per cent on the day, trading at C$0.55 per share at 1:50 pm EST.

More From The Market Herald
HEXO - CEO, Scott Cooper.

" HEXO (TSX:HEXO) delineates its path forward

HEXO (HEXO) has announced cost-saving initiatives to carry the company into the future.

" Tinley’s (CSE:TNY) makes production announcement, closes first tranche of private placement

The Tinley Beverage Company (TNY) will begin making Green Monké products at its Long Beach facility.

" Tinley (CSE:TNY) announces first product clearance under California distribution license

The Tinley Beverage Company (TNY) has released an update regarding products manufactured at its Long Beach facility.

" CENTR Brands (CSE:CNTR) grows retail distribution

CENTR’s (CNTR) retail distribution has increased to 2,100 U.S. locations as of December 2021.